CUSIP: 30063P105
Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
193,646,400
-
Total 13F shares
-
161,551,605
-
Share change
-
-6,570,854
-
Total reported value
-
$5,251,627,398
-
Put/Call ratio
-
125%
-
Price per share
-
$32.49
-
Number of holders
-
445
-
Value change
-
-$244,501,208
-
Number of buys
-
216
-
Number of sells
-
200
Security key
30063P105
Report period
Q3 2022
Institutions
445
Top holders
10
Reporting periods
Holder history for CUSIP 30063P105
Recent filing periods:
Top shareholders of EXAS - EXACT SCIENCES CORP - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of EXACT SCIENCES CORP - Common Stock (EXAS) as of Q3 2022
As of 30 Sep 2022,
EXACT SCIENCES CORP - Common Stock (EXAS) was held by
445 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
161,551,605 shares.
The largest 10 holders included
ARK Investment Management LLC, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, Capital World Investors, and BAILLIE GIFFORD & CO.
This page lists
446
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q3 2022 vs Q2 2022 Across Filers
| Investor |
Q2 2022 Shares |
Q3 2022 Shares |
Share Diff |
Share Chg % |
Q2 2022 Value $ |
Q3 2022 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.